STAT3 is required for Smo‐dependent signaling and mediates Smo‐targeted treatment resistance and tumorigenesis in Shh medulloblastoma-Reference-Cited by-同舟云学术

STAT3 is required for Smo‐dependent signaling and mediates Smo‐targeted treatment resistance and tumorigenesis in Shh medulloblastoma

Published:2021-09-25 Issue: Volume: Page:
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Yuan Liangping¹,Zhang Hongying¹,Liu Jingbo¹,Malhotra Anshu¹,Dey Abhinav¹,Yu Bing¹,Jella Kishore Kumar¹,McSwain Leon F.¹,Schniederjan Matthew J.²,MacDonald Tobey J.¹³^ORCID

Affiliation:

1. Department of Pediatrics Emory University School of Medicine Atlanta GA USA

2. Department of Pathology and Laboratory Medicine Children's Healthcare of Atlanta Emory University School of Medicine Atlanta GA USA

3. Aflac Cancer & Blood Disorders Center Children's Healthcare of Atlanta Emory University School of Medicine Atlanta GA USA

Funder

CURE Childhood Cancer Association

Ian's Friends Foundation

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13097

Reference69 articles.

1. Molecular Classification of Medulloblastoma

2. Molecular subgroups of medulloblastoma: the current consensus

3. Medulloblastoma Comprises Four Distinct Molecular Variants

4. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study

5. Gli1 is important for medulloblastoma formation in Ptc1+/− mice

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of STAT3: A promising approach to enhancing the efficacy of chemotherapy in medulloblastoma;Translational Oncology;2024-08

2. Recent advances in hematopoietic cell kinase in cancer progression: Mechanisms and inhibitors;Biomedicine & Pharmacotherapy;2024-07

3. Targeting Super-Enhancer–Driven Transcriptional Dependencies Suppresses Aberrant Hedgehog Pathway Activation and Overcomes Smoothened Inhibitor Resistance;Cancer Research;2024-05-22

4. Celastrol can inhibit the growth of SHH medulloblastoma: In vitro and in vivo studies;2024-01-08

5. PCBP1 regulates LIFR through FAM3C to maintain breast cancer stem cell self-renewal and invasiveness;Cancer Biology & Therapy;2023-11-06